Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Recruitment initiated in phase II trial of CicloMulsion for acute kidney injury

April 28, 2015

Merck & Co. presents novel MR antagonists

April 16, 2015

Phase IIb trial of Nefecon for primary IgA nephropathy meets primary endpoint

April 14, 2015

Hydra Biosciences and Boehringer Ingelheim collaborate on TRP inhibitors for renal diseases

April 14, 2015

New Drosophila model of nephrolithiasis presented

April 10, 2015

sGC activators prevent progression of diabetic nephropathy

April 8, 2015

Thrasos Therapeutics secures funds to complete phase II study of THR-184

April 2, 2015

Toray describes highly potent alpha1L-adrenoceptor agonists

March 30, 2015

Università degli Studi di Padova describes use of SERPINB3 for SLE

March 26, 2015

Regulus receives European orphan medicinal product designation for RG-012

March 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...